You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
舒泰神(300204.SZ):BDB-001注射液用於治療冠狀病毒感染所致重症肺炎治療的臨牀試驗申請獲受理
格隆匯 02-04 17:46

格隆匯2月4日丨舒泰神(300204.SZ)公佈,公司股票連續兩個交易日(2020年02月03日、2020年02月04日)收盤價格漲幅偏離值累計超過20%,根據《深圳證券交易所交易規則》的相關規定,屬於股票交易異常波動的情況。

自新型冠狀病毒肺炎疫情發生以來,引起了社會廣泛關注。舒泰神及子公司德豐瑞根據《國家食品藥品監督管理局藥品特別審批程序》申報的關於BDB-001注射液用於治療冠狀病毒感染所致重症肺炎的治療的臨牀試驗和BDB-001注射液用於治療冠狀病毒感染所致相關疾病的治療的臨牀試驗申請均已於2020年01月31日獲得國家藥品監督管理局的受理。

此次新藥臨牀試驗申請以支持有效疫情防控,保障公眾生命安全與身體健康為初心,公司將持續春節假期無休的奮鬥精神,克服疫情當前的多重困難,再接再勵推進上述項目的下一步工作。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account